Screening Serum Differential Proteins in Children with Acute Promyelocytic Leukemia Based on iTRAQ Technique

Run-Hong YU; Jing-Yu ZHANG; Yu-Feng LIU; Zun-Min ZHU.
Journal of Experimental Hematology ; (6): 1462-1470, 2021.
Artículo en Zh | WPRIM | ID: wpr-922280

Documentos relacionados

  1. [Screening Serum Differential Proteins in Children with Acute Promyelocytic Leukemia Based on iTRAQ Technique].
  2. Inhibition of splicing factors SF3A3 and SRSF5 contributes to As<sup>3+</sup>/Se<sup>4+</sup> combination-mediated proliferation suppression and apoptosis induction in acute promyelocytic leukemia cells.
  3. Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge.
  4. [Diagnostic efficacy of WT1 expression in asymptomatic acute promyelocytic leukemia].
  5. Acute Promyelocytic Leukemia: Update on Risk Stratification and Treatment Practices.
  6. Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report.
  7. Various types of electrochemical biosensors for leukemia detection and therapeutic approaches.
  8. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.
  9. The Importance of Rapid Laboratory Diagnosis of Acute Promyelocytic Leukemia.
  10. Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.